The African polio vaccine-acquired immune deficiency syndrome connection.
Seroepidemiological, clinical and molecular findings suggest that the acquired immune deficiency syndrome virus human immunodeficiency virus-1 was introduced into the human species at the time (late 1950s) and in the geographic area (Zaire) in which millions of Africans were vaccinated with attenuated poliomyelitis virus strains that were produced in kidney tissue obtained from monkeys. Since monkeys not only harbor viruses that are remarkably similar to and genetically related to human immunodeficiency virus-1, but also served as tissue donors for the African polio vaccine, it is reasonable to suspect that a then non-detectable monkey virus with human-1-like properties was unknowingly co-cultured with the attenuated poliovirus virus and subsequently administered to the vaccinees. The possibility of such a polio vaccine-acquired immune deficiency syndrome connection is a reminder of the unpredictable danger of artifically crossing natural species-barriers in biomedical laboratories.
Reinhardt
V
V
Animal Welfare Institute, Washington, DC 20007, USA.
Roberts
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000266:history / Q000635:transmission*; D000349:Africa; D000818:Animals; D002986:Clinical Trials as Topic / Q000009:adverse effects / Q000266:history; D046508:Culture Techniques / Q000009:adverse effects / Q000266:history / Q000379:methods; D004197:Disease Reservoirs; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity; D000882:Haplorhini / Q000821:virology; D049673:History, 20th Century; D006801:Humans; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects* / Q000266:history / Q000302:isolation & purification; D015302:Simian Immunodeficiency Virus / Q000302:isolation & purification / Q000472:pathogenicity; D014776:Virus Cultivation / Q000009:adverse effects / Q000266:history / Q000379:methods
D011054:Poliovirus Vaccine, Inactivated